Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31469524 | 1.00 | TDP1 (0.50) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL29104740 | 0.84 | TDP1 (0.52) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL27535060 | 0.82 | TDP1 (0.41) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL7276080 | 0.80 | TDP1 (0.48) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL425735 | 0.80 | TDP1 (0.48) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL6225790 | 0.80 | TDP1 (0.48) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL13967844 | 0.80 | TDP1 (0.48) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL1020469 | 0.80 | TDP1 (0.48) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL712304 | 0.80 | TDP1 (0.48) | TDP1ALDH1A1TSHRLMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL4305676 | 0.78 | TDP1 (0.47) | TDP1ALDH1A1TSHRLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727537-A2 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | Adaxion Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20250064941-A1 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | ADAXION THERAPEUTICS, INC. | 2025-02-27 | — | — | US | disclosed |
| WO-2024259007-A2 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | OSPREY BIOPHARMACEUTICALS, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20160151261-A1 | STABLE COSMETIC COMPOSITION CONTAINING A MONOGLYCERIDE, A TARTARIC ESTER OF MONOGLYCERIDE, AND A COATED FILLER | L'OREAL (FR) | 2016-06-02 | — | — | US | disclosed |
| US-20120065227-A1 | TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2012-03-15 | — | — | US | disclosed |
| US-8124806-B2 | Contrast agents | GE HEALTHCARE AS (NO) | 2012-02-28 | — | — | US | disclosed |
| US-8124806-B2 | Contrast agents | GE HEALTHCARE AS (NO) | 2012-02-28 | — | — | US | disclosed |
| US-8124806-B2 | Contrast agents | GE HEALTHCARE AS (NO) | 2012-02-28 | — | — | US | disclosed |
| US-8088792-B2 | Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088792-B2 | Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20080260651-A1 | CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2008-10-23 | — | — | US | disclosed |
| US-20080260651-A1 | CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2008-10-23 | — | — | US | disclosed |
| WO-2008123779-A1 | TRISUBSTITUTED TRIAZAMACROCYCLI C COMPOUNDS AND THEIR USE AS CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008123779-A1 | TRISUBSTITUTED TRIAZAMACROCYCLI C COMPOUNDS AND THEIR USE AS CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2008-10-16 | — | — | WO | disclosed |
| WO-2007094683-A1 | CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007094683-A1 | CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2007-08-23 | — | — | WO | disclosed |
| EP-0755372-A4 | INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE AND METHODS OF MAKING AND USING THE SAME | UNIV ALABAMA (US) | 1997-09-10 | — | — | EP | disclosed |
| EP-0755372-A1 | INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE AND METHODS OF MAKING AND USING THE SAME | THE UNIVERSITY OF ALABAMA AT BIRMINGHAM (US) | 1997-01-29 | — | — | EP | disclosed |
| WO-1995028376-A1 | INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE AND METHODS OF MAKING AND USING THE SAME | THE UNIVERSITY OF ALABAMA AT BIRMINGHAM (US) | 1995-10-26 | — | — | WO | disclosed |
| US-5453533-A | Enzyme inhibitor | THE UNIVERSITY OF ALABAMA AT BIRMINGHAM (US) | 1995-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065227-A1 | TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS | SCD, SCD5, FASN | TDP1 1555/4885ALDH1A1 1275/4885TSHR 3633/4885 |
| US-20160151261-A1 | STABLE COSMETIC COMPOSITION CONTAINING A MONOGLYCERIDE, A TARTARIC ESTER OF MONOGLYCERIDE, AND A COATED FILLER | MGLL, DAGLA, GLA | TDP1 461/4885ALDH1A1 1774/4885TSHR 3447/4885 |
| US-20080260651-A1 | CONTRAST AGENTS | IPO4, TPO, IPO11 | TDP1 2931/4885ALDH1A1 3375/4885TSHR 420/4885 |
| US-20250064941-A1 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | SIGLEC7, SIGLEC9, CD2BP2 | TDP1 2616/4885ALDH1A1 802/4885TSHR 1160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.